» Articles » PMID: 19171835

Vascular Risk Factors and Dementia: How to Move Forward?

Overview
Journal Neurology
Specialty Neurology
Date 2009 Jan 28
PMID 19171835
Citations 157
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, accumulating evidence has suggested that vascular risk factors contribute to Alzheimer disease (AD). Vascular dementia had been traditionally considered secondary to stroke and vascular disease. It has been traditionally distinguished from AD, considered to be a purely neurodegenerative form of dementia. However, in light of this more recent literature, it appears that there is a spectrum: ranging from patients with pure vascular dementia to patients with pure AD and including a large majority of patients with contributions from both Alzheimer and vascular pathologies. In this article, we discuss the impact of vascular risk factors on AD and its consequences at the individual level and at the population level by highlighting the concept of attributable risk. We then discuss the key questions and next steps involved in designing a therapeutic trial to control vascular risk factors for the prevention of dementia.

Citing Articles

Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types.

Holtman I, Glass C, Nott A Adv Neurobiol. 2024; 37:531-544.

PMID: 39207711 DOI: 10.1007/978-3-031-55529-9_29.


Serum Levels of Plasminogen Activator Inhibitor-1 in Patients with Parkinson's Disease.

Tanrikulu A, Ozdilek B, Agirbasli M Med Princ Pract. 2024; 33(6):562-568.

PMID: 39134015 PMC: 11631035. DOI: 10.1159/000540854.


Neurovascular coupling, functional connectivity, and cerebrovascular endothelial extracellular vesicles as biomarkers of mild cognitive impairment.

Owens C, Pinto C, Mukli P, Gulej R, Velez F, Detwiler S Alzheimers Dement. 2024; 20(8):5590-5606.

PMID: 38958537 PMC: 11350141. DOI: 10.1002/alz.14072.


Prediction of dementia risk from multimodal repeated measures: The added value of brain MRI biomarkers.

Bercu A, Dufouil C, Debette S, Joliot M, Tsuchida A, Helmer C Alzheimers Dement (Amst). 2024; 16(2):e12578.

PMID: 38800122 PMC: 11127684. DOI: 10.1002/dad2.12578.


Genetic Complexities of Cerebral Small Vessel Disease, Blood Pressure, and Dementia.

Sargurupremraj M, Soumare A, Bis J, Surakka I, Jurgenson T, Joly P JAMA Netw Open. 2024; 7(5):e2412824.

PMID: 38776079 PMC: 11112447. DOI: 10.1001/jamanetworkopen.2024.12824.


References
1.
Wolozin B, Wang S, Li N, Lee A, Lee T, Kazis L . Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med. 2007; 5:20. PMC: 1955446. DOI: 10.1186/1741-7015-5-20. View

2.
Mielke M, Rosenberg P, Tschanz J, Cook L, Corcoran C, Hayden K . Vascular factors predict rate of progression in Alzheimer disease. Neurology. 2007; 69(19):1850-8. DOI: 10.1212/01.wnl.0000279520.59792.fe. View

3.
Orgogozo J, Rigaud A, Stoffler A, Forette F . Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke. 2002; 33(7):1834-9. DOI: 10.1161/01.str.0000020094.08790.49. View

4.
Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju C . Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002; 359(9314):1283-90. DOI: 10.1016/S0140-6736(02)08267-3. View

5.
Roman G, Tatemichi T, Erkinjuntti T, Cummings J, Masdeu J, Garcia J . Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43(2):250-60. DOI: 10.1212/wnl.43.2.250. View